Pharmacologic Inhibition of SIRT1 Limits the Growth of Tumoral and Metastatic Granulosa Cells by Affecting mTOR, Myc, and E2F Pathways
Year: 2025
Type: article
Source: Molecular Cancer Therapeutics
Institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Unit of Functional and Adaptive Biology, Health and Functional Exposomics, Université Paris-Saclay, Institut Gustave Roussy, Physiopathologie et pharmacotoxicologie placentaire humaine : Microbiote pré & post natal, National Institutes of Health, National Cancer Institute, Center for Cancer Research
Language: English
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409086335
